Menu

Yann HYVERT

BEAUMONT

En résumé

Highly driven scientific and biomarker within clinical development expert
Expertise in neurodegeneration and inflammation therapeutic areas.
- Understanding of R&D processes from pre-clinical, translational until late clinical development stages
- Specialized in setting up biomarker and pharmacogenomic development strategies

Mes compétences :
Biologie
Recherche

Entreprises

  • EMD Serono - Senior Scientist

    2013 - maintenant

  • Merck Serono S.A. - Biomarker Scientist

    2010 - 2013 - Lead biomarker and pharmacogenomic development within clinical projects in multiple sclerosis
    - Contribute to biomarker development strategy
    - Lead project subteam to implement biomarker strategy
    Specialist Scientist Biomarker in Autoimmune and Neurodegenerative

  • Merck Serono S.A. - Biomarkers Scientific Specialist

    2008 - 2010 - Provided scientifc input and write scientific rational for clinical development and regulatory documents
    - Acted as coordinator for biomarker and pharmacogenomics activities for several studies
    - Supported biomarker development plans generation

  • Université Louis Pasteur - PhD student

    2004 - 2007

Formations

Annuaire des membres :